HBsAg loss with HBsAg/anti-HBs seroconversion and non-detectable HCV-RNA in a patient with chronic HBV e-minus/HCV hepatitis treated with two cycles of antiviral therapy

Introduction: Loss of HBsAg is observed in only 3-4% of patients who receive interferon for chronic HBV+HCV hepatitis, and there are few reports of HBsAg loss induced by treatments other than interferon. We report a case of chronic HBV+HCV hepatitis, in which a positive outcome was achieved with a n...

Full description

Bibliographic Details

Published in:	Italian Journal of Medicine
Main Authors:	Antonio Salvio, Maria Varriale, Tito d’Errico, Gennaro De Siena, Mario Visconti
Format:	Article
Language:	English
Published:	PAGEPress Publications 2012-01-01
Subjects:	Chronic hepatitis Coinfection Hepatitis B Virus (HBV) Hepatitis C Virus (HCV) Peginterferon-alfa Ribavirin.
Online Access:	http://www.italjmed.org/index.php/ijm/article/view/116